Stocklytics Platform
Asset logo for symbol PODD
Insulet
PODD74
$259.38arrow_drop_up5.25%$12.94
High Quality
S&P500
Asset logo for symbol PODD
PODD74

$259.38

arrow_drop_up5.25%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Insulet (PODD) Stocklytics Forecast

According to analysts, Insulet Corp (PODD) stock shows promising potential for the coming years. The stock price prediction for Insulet Corp suggests a positive trend, with expected growth in the near future. Based on data-driven analysis and market trends, it is projected that the stock will continue to perform well.
Insulet Corp has been developing innovative technologies in the healthcare sector, particularly in the field of diabetes management. Their flagship product, the Omnipod System, has gained significant popularity and is expected to contribute to the company's growth. The demand for insulin delivery systems is rising, and Insulet Corp is well positioned to meet this demand.
add Insulet to watchlist

Keep an eye on Insulet

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Insulet (PODD) stock?

Analysts have set a target price of $238.79 for Insulet (PODD), based on forecasts from 29 analysts. The predicted price range extends from a high of $330 to a low of $162. This represents a potential increase of up to 27.23% and a decrease of -37.54% from the current price of $259.38. These forecasts are as of 2023 Aug 09.
help

What are the analyst ratings for Insulet (PODD) stock?

The analyst ratings for Insulet (PODD) are distributed as follows: 20 analysts recommend buying, 4 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 24 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Insulet.
help

What is the AI price prediction for Insulet (PODD) stock?

At present, there is no AI or machine-learning-based price prediction available for Insulet (PODD) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level